Max Hospital, Pitampura

Details Associates
Medical Suppliers In Delhi

Name :

Max Hospital, Pitampura

Address  :

Near TV Tower, Pitampura
Wazirpur District Centre

Town  :

New Delhi

State  :

Delhi

Country  :

INDIA

Post Code:

110 034

Phone  :

91 11 2735 1844

Fax  :

91 11 2735 7229

Web URL  :

Available
Max Hospital Pitampura
Specialization
  • Anaesthesiology
  • Daibetes, Endocrinology
  • Dermatology
  • ENT
  • Gastro-enterology
  • Internal Medicine
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Paediatrics
  • Psychiatrist
  • Urology
Facilities

Total Number Of Beds : 100

Other Facilities

  • Pathology

Advance Facility

  • Medicine Facility
  • Medical Stores
Description
Max Hospital Pitampura is ideally located in Pitampura North Delhi opposite Netaji Subhash Place Metro Station Pathology Labs at Max Hospital Pitampura have been accredited with NABL certification

Infrastructure It is an ISO 90012000 and 140012004 accredited centrally airconditioned 100bed facility with VIP single double 3bed and 4bed rooms three operation theatres and a 12bed ICU

Services amp Facilities The clinical services are supported with the most advanced inhouse diagnostic services supported by 24hour emergency response and management system The hospital has other specialised services like neonatal ICU NICU an endoscopy suite and a dialysis facility

OTs amp ICUs The hospital has three operation theatres and a 12bed ICU The operation theatre complex is located on the ninth floor amp seventh floors with HEPA filters laminar flow amp electric conducting floor
NEWS
Apollo Hospitals to open new unit in Ahmedabad

National healthcare chain Apollo Group of Hospitals after deciding to increase thenumber of beds in their Gandhinagar setup have now planned to come up with one more unit in Ahmedabad The existing Apollo Hospital City Centre near Parimal Garden in Ahmedabad will be shifted to a nearby location and a new hospital specialising in heart care will be b... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More